Management
A strong team
Dr. Martin Renner
CEO
Martin is a pharmacist and studying pharmacy in Düsseldorf. He received his PhD in Pharmaceutical Technology in 2004.
He started his career in a global pharmaceutical company. In a wide variety of international management positions in the group, he took over various site managements with different dosage forms from 2013.
Based on his management experience, his pharmaceutical-technological know-how as well as his friendly and charming as well as purposefully structured management style, he has already made positive progress on several milestones at Develco since the beginning of 2020.
Dr. Marc Fischer
COO
As Chief Operating Officer, Marc is responsible for the operational areas of administration, human resources and IT. He has a doctorate in chemistry with training in Lyon and Milwaukee.
Based on his professional experience as head of analytical development at CIMEX AG in the Basel area, he was one of the founding members of Develco Pharma in 2006. There, initially as head of analytical development, he made a significant contribution to the start-up success of the young company. From the beginning, Marc has successfully programmed and set up the ERP system that is still used today.
Due to his varied interest in economic and operational topics, Marc has been Chief Operating Officer since April 2009 and was also in charge of finances until September 2013.
Dr. Hélène Rey
Research & Development
As Head of Research and Development, Helene is our creative director. Characterized by a wonderful mixture of detective analysis and targeted creativity.
Helene has always found a way to circumvent an existing formulation patent and now holds some innovative formulation patents herself.
Helene is fluent in three languages, she grew up in France, did her doctorate in pharmacy in Germany and has been working in the international English-speaking pharmaceutical industry in Switzerland.
She is co-founder of Develco and responsible for analytical, pharmaceutical and clinical development, pilot production, intellectual property and regulatory affairs.
Markus Gerstner
Chief Financial Officer
Annette Steiner-Kienzler
Managing Director Schopfheim
Annette Steiner-Kienzler took over the management of Develco Pharma GmbH Schopfheim in November 2023.
As someone who is known for her enthusiasm and change management, she is particularly looking forward to working with the employees to continue the company’s growth. With over 20 years of professional experience in the pharmaceutical industry, including at one of the international Big Five in the industry, she has successfully managed the entire E&E value chain from development to production, packaging and strategic placement of products on the market. Annette is an expert in solida and high-potent pharmaceutical manufacturing.
True to the motto: “Be the change you want to see in the world”, she has actively managed transformation and restructuring processes in the CDMO sector.
As a convinced alpinist, Annette likes to live by the motto: “I go to a summit and when I come back down, I am a different person”.
With this in mind, let’s take off together.
Roberto Curseri-Rödiger
Head of Corporate Quality
Roberto will take over the management of the quality units in the Develco Group from 1st December 2023 succeeding Dr. Martina Maritz.
After more than 25 years of experience in the field of Quality & Regulatory Affairs, Roberto is an expert in quality management in internationally operating pharmaceutical companies and for medical devices. He has 13 years of well-founded experience as a technical person responsible (FvP) and as a narcotics authorised representative.
Roberto started his professional career as an analytical chemistry laboratory technician at the Food Safety Office and then completed the BSc in Chemical Engineering and the MSc in Biotechnology. He has complemented his knowledge of pharmaceuticals with further GMP training in Heidelberg and Copenhagen as well as a degree of excellence studies for quality management.
Roberto’s strengths are pharmaceutical analytics as well as quality management systems. Especially in the combination of cGMP with lean management and excellence standards, he has a solid experience. He brings leadership skills and abilities in structural organizational development.
Unconditional commitment to high quality and a lively improvement process are his priorities; his commitment as well as his friendliness are his trademarks.
